8.0 Dose of Therapeutic Modifications 
Patients can receive medications to control any side effects 
of treatment. Such agents would include acetaminophen (650 mg. 
q. 4 hrs.), indomethacin (50-75 mg. q. 6 hrs.), or antihistamines 
as required. Glucocorticoids will not be used in these patients; 
or if such medication is required, the patient will be removed 
from the protocol. 
[718] 
Recombinant DNA Research, Volume 17 
